Mechanical reperfusion and long-term survival in latecomerswith ST-elevation myocardial infarction

Authors: E.V. Konovalova, Yu.V. Luk’yanova, D.V. Skrypnik, R.Yu. Reztsov, O.V. Makarycheva, E.Yu. Vasilieva, A.V. Shpektor

Company: A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of the RF, ul. Delegatskaya, 20, stroenie 1, Moscow, 127473, Russian Federation


Keywords: revascularization acute coronary syndrome survival prognosis

Full text:  

 

References

1. Antman E.M., Hand M., Armstrong P.W. et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society, endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, writing on behalf of the 2004 Writing Committee. J. Am. Coll. Cardiol. 2008; 51: 210–47.
2. Van de Werf F., Bax J., Betriu A. et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur. Heart J. 2008; 29: 2909–45.
3. Fesmire F.M., Brady W.J., Hahn S. et al. Clinical policy: indications for reperfusion therapy in emergency department patients with suspected acute myocardial infarction. American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Reperfusion Therapy in Emergency Department Patients with Suspected Acute Myocardial Infarction. Ann. Emerg. Med. 2006; 48: 358–83.
4. Wijns W., Kolh Ph., Danchin N. et al. Guidelines on myocardial revascularization. Eur. Heart J. 2010; 31: 2501–55.
5. Boden W., Eagle K., Granger C. Reperfusion strategies in acute ST-segment elevation myocardial infarction. JACC. 2007; 50: 917–29.
6. Steg Ph. G., James S.K. et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J. 2012; 33: 2569–619.
7. Eagle K.A., Nallamothu B.K., Mehta R.H. et al. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur. Heart J. 2008; 29: 609–17.
8. Zeymer U., Gitt A.K., Jünger C. et al. Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial infarction. Thromb. Haemost. 2008; 99: 155–60.
9. Schömig A., Mehilli J., Antoniucci D., Ndrepepa G., Markwardt C., Di Pede F. et al. Beyond 12 hours Reperfusion Alternative Evaluation (BRAVE-2) Trial Investigators. JAMA. 2005; 293 (23): 2865–72.
10. Hochman J.S., Lamas G.A., Knatterud G.L., Buller C.E., Dzavik V., Mark D.B. et al.; Occluded Artery Trial Research Group. Design and methodology of the Occluded Artery Trial (OAT). Am. Heart J. 2005; 150 (4): 627–42.
11. Ndrepepa G., Kastrati A., Mehilli J., Antoniucci D., Schömig A. Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12 to 48 hours from onset of symptoms. JAMA. 2009; 301 (5): 487–8.
12. Makarycheva O., Lukianova Yu., Vasilieva E., Shpektor A. Reperfusion in acute myocardial infarction with ST elevation more than 12 hours after the onset of symptoms. European Society of Cardiology Congress 2012. Eur. Heart J. 2012; 33: 470.
13. Makarycheva O., Lukianova Yu., Vasilieva E., Shpektor A. PCI in STEMI patients admitted more than 12 hours after the onset of symptoms. Acute Cardiovascular Care 2012. Eur. Heart J. 2012; 7: 351.
14. Шпектор А.В., Васильева Е.Ю. Острый инфаркт миокарда с подъемом сегмента ST на ЭКГ (кли- ническая лекция). Креативная кардиология. 2007; 1–2: 277–313.
15. Лукьянова Ю.В., Макарычева О.В., Василье- ва Е.Ю., Шпектор А.В. Эффективность первич- ного чрескожного коронарного вмешательства у пациентов с острым инфарктом миокарда с подъемом сегмента ST, проведенного при позд- нем (позднее 12 часов) поступлении в стацио- нар. Креативная кардиология. 2011; 2: 37–41.
16. Лукьянова Ю.В., Скрыпник Д.В., Назаров А.В. Особенности ангиографической картины и на- рушений сократимости миокарда у больных ос- трым инфарктом миокарда с подъемом сегмен- та с поражением правого желудочка. Врач ско- рой помощи. 2011; 9: 59–60.
17. Лукьянова Ю.В. Чрескожное коронарное вме- шательство у пациентов в поздние (позднее 12 часов) сроки инфаркта миокарда с подъемом сегмента ST. Хирургия. 2012; 6: 16.
18. Голухова Е.З., Какучая Т.Т. Клеточная терапия в кардиологии и сердечно-сосудистой хирургии: обзор рандомизированных исследований. Реа- лии и перспективы. Креативная кардиология. 2007; 1–2: 55–74.
19. Ioannidis J.P., Katritsis D.G. Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patients. Am. Heart J. 2007; 154: 1065–71.
20. Dzavík V., Buller C.E., Lamas G.A. et al. TOSCA-2 Investigators. Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial. Circulation. 2006; 114: 2449–57.
21. Yousef Z.R., Redwood S.R., Bucknall C.A. et al. Late intervention after anterior myocardial infarction: effects on left ventricular size, function, quality of life, and exercise tolerance: results of the Open Artery Trial (TOAT Study). J. Am. Coll. Cardiol. 2002; 40: 869–76.
22. Abbate A., Biondi-Zoccai G.G., Appleton D.L. et al. Survival and cardiac remodeling benefits in patients undergoing late percutaneous coronary intervention of the infarct-related artery: evidence from a metaanalysis of randomized controlled trials. J. Am. Coll. Cardiol. 2008; 51: 956–64.
23. Ellis S.G., Mooney M.R., George B.S. et al. Randomized trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment of myocardial infarction. Treatment of Post-Thrombolytic Stenoses (TOPS) Study Group. Circulation. 1992; 86: 1400–6.
24. Zeymer U., Uebis R., Vogt A. et al. Randomized comparison of percutaneous transluminal coronary angioplasty and medical therapy in stable survivors of acute myocardial infarction with single vessel disease: a study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte. Circulation. 2003; 108: 1324–8.
25. Erne P., Schoenenberger A.W., Burckhardt D. et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA. 2007; 297: 1985–91.

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery